SCHEMBL4733740

SCHEMBL4733740

Cc1ccc(-c2cc3c(c(C(=O)O)c2)OCC3)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.49
AKR1C2 P52895 1/20 0.48
AKR1C1 Q04828 1/20 0.48
XDH P47989 1/20 0.44
SLC22A12 Q96S37 1/20 0.44
FABP4 P15090 6/20 0.43
PARP1 P09874 2/20 0.42
DHODH Q02127 1/20 0.39
FTO Q9C0B1 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 2/20 0.38
LMNA P02545 1/20 0.38
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735627 0.88 PARP1 (0.44) MCL1AKR1C2AKR1C1XDHSLC22A12
SCHEMBL4735319 0.87 XDH (0.48) MCL1XDHSLC22A12FABP4PARP1
SCHEMBL4735090 0.86 XDH (0.43) AKR1C2XDHSLC22A12FABP4PARP1
SCHEMBL4736983 0.86 XDH (0.44) AKR1C2AKR1C1XDHSLC22A12FABP4
SCHEMBL4733776 0.86 PARP1 (0.52) AKR1C2AKR1C1XDHSLC22A12FABP4
SCHEMBL4739429 0.85 SMN1; SMN2 (0.50) MCL1AKR1C2XDHSLC22A12PARP1
SCHEMBL4736525 0.85 XDH (0.42) MCL1XDHSLC22A12FABP4PARP1
SCHEMBL4785932 0.83 ACMSD (0.49) MCL1AKR1C2AKR1C1XDHSLC22A12
SCHEMBL1510051 0.83 XDH (0.44) MCL1XDHSLC22A12FABP4PARP1
SCHEMBL4738878 0.83 SMN1; SMN2 (0.47) XDHSLC22A12PARP1DHODHSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US claimed
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US disclosed
WO-2008071455-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 MCL1 3416/4885AKR1C2 610/4885AKR1C1 609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.